Long-Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial.


Tanton, C; Weiss, HA; Rusizoka, M; Legoff, J; Changalucha, J; Baisley, K; Mugeye, K; Everett, D; Belec, L; Clayton, TC; Ross, DA; Hayes, RJ; Watson-Jones, D; (2010) Long-Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial. The Journal of infectious diseases, 201 (9). pp. 1285-97. ISSN 0022-1899 DOI: https://doi.org/10.1086/651696

Full text not available from this repository. (Request a copy)

Abstract

Herpes simplex virus (HSV) suppressive therapy reduces genital and plasma human immunodeficiency virus type 1 (HIV-1) RNA over periods up to 3 months, but the long-term effect is unknown.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Faculty of Epidemiology and Population Health > Dept of Medical Statistics
Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
Tropical Epidemiology Group
Centre for Maternal, Reproductive and Child Health (MARCH)
PubMed ID: 20235836
Web of Science ID: 276248400003
URI: http://researchonline.lshtm.ac.uk/id/eprint/3958

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
378Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item